AU:PAR Stock Latest News
Company AnnouncementsParadigm Biopharmaceuticals Enters Administration After Phase 3 Trial Fails Futility Threshold2w ago
Company AnnouncementsParadigm Biopharmaceuticals Wins Extension for Key Creditors’ Meeting2w ago- Company AnnouncementsParadigm Administrators Seek Court Extension to Buy Time for Rescue Plan3w ago
Company AnnouncementsParadigm Biopharmaceuticals Redeems Convertible Notes Without Equity Conversion3w ago
Company AnnouncementsParadigm Biopharma Redeems Further Obsidian Convertible Notes Amid Administration3w ago
Company AnnouncementsParadigm Biopharmaceuticals Options Lapse, Simplifying Capital Structure3w agoCompany AnnouncementsParadigm Biopharmaceuticals Options to Expire Unexercised Amid Voluntary Administration1M ago
Company AnnouncementsParadigm Redeems More Convertible Notes and Flags Issues in Phase 3 Trial Data1M ago
Company AnnouncementsParadigm Biopharmaceuticals Shares Suspended as ASX Flags Financial Breach1M ago- Company AnnouncementsParadigm Biopharmaceuticals Enters Voluntary Administration1M ago
Company AnnouncementsParadigm Extends Trading Suspension Pending Phase 3 Data Review1M ago
Company AnnouncementsParadigm Biopharmaceuticals Cancels 2 Million Convertible Notes1M ago
Company AnnouncementsParadigm Biopharmaceuticals Halts Trading Ahead of Phase 3 Trial Update1M ago
Company AnnouncementsParadigm Biopharmaceuticals Seeks Quotation for 600,000 New ASX Shares1M ago
Company AnnouncementsParadigm Biopharmaceuticals reshapes medical leadership as Phase 3 osteoarthritis trial advances2M ago- Company AnnouncementsParadigm Biopharmaceuticals Lists Additional Shares on ASX2M ago
Company AnnouncementsParadigm Biopharmaceuticals issues cleansing notice for new convertible notes tranche2M agoCompany AnnouncementsParadigm Secures Further Funding as Knee Osteoarthritis Phase 3 Trial Fully Enrolled2M ago
